Investing Profile

Briggs Morrison

VC
Managing Director at MPM Capital
Photo of Briggs Morrison, Managing Director at MPM Capital
Your Intro Paths to Briggs Morrison

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Briggs is a member of
Georgetown University Network
195 CONNECTIONS
Pfizer Network
78 CONNECTIONS
Merck Network
59 CONNECTIONS
MPM BioImpact Network
34 CONNECTIONS
AstraZeneca Network
28 CONNECTIONS

Find Briggs Morrison on

cb
Current Investing Position
MPM Capital Managing Director
Investments On Record
1
Current Fund Size
$100M

Briggs Morrison is on these Sector & Stage Rankings

Briggs Morrison's Investments On Record (1)

CompanyStageDateRound SizeTotal Raised
Photys Therapeutics
Series ASep 2022$75M
$75M
Co-investors: David Steinberg (Longwood Fund), Luke Evnin (Scleroderma Research Foundation)

Briggs Morrison's Experience

Managing Director MPM Capital2015 - Present
various MerckPresent
Chief Medical Officer and Executive Vice President, Global Medicines Development AstraZenecaPresent
Board Member Syndax PharmaceuticalsPresent
Board Member ArvinasPresent
Board Member Werewolf TherapeuticsPresent
President, Head of R+D Syndax PharmaceuticalsPresent
Board Member CRISPR TherapeuticsPresent
Board Chair ArvinasPresent
Executive Partner MPM BioImpactPresent
Chief Executive Officer Crossbow Therapeutics, IncPresent
CEO Syndax Pharmaceuticals2015 - 2022
Executive Vice President, Global Medicines Development AstraZeneca2012 - 2015
SVP Pfizer2007 - 2011
various Merck & Co., Inc1995 - 2007

Briggs Morrison's Education

Dana Farber Cancer Institute Fellowship Medical Oncology
Mass General Hosipital Intern/Resident Internal Medicine
The University of Connecticut Health Center MD Medicine
Georgetown University Bachelor of Science (BS) Biology, General

Investors who invest with Briggs Morrison

Sign in with Google →

Scouts & Angels Affiliated With Briggs Morrison

Sign in with Google →